Press

ELITE GROUP OF EMERGING MEDTECH START-UPS SEEK $385M IN NEW FINANCING

HUNTINGTON BEACH , Calif.-February 2008--(BUSINESS WIRE)-- Life Science Intelligence (LSI) announced this month that a new group of 39 privately-held medtech companies has recently been added to the EMT (Emerging Medical Technologies) Database. LSI's EMT Database provides venture capitalists and medical technology companies with a searchable online resource allowing them to discover, partner, and capitalize on opportunities in emerging medtech start-up companies.

According to LSI, this latest round of companies added to the EMT Database is collectively seeking over $385M in financing as follows: $1M Seed, $55.9M Series A, $20M Series B, $70M Series C, $60M Series D, $69M Series F, and $109.6M Undisclosed. Many of the companies are also actively pursuing strategic partnerships and licensing deals with large medtech companies.

Various markets represented by start-ups in the EMT Database include: aesthetics, biomaterials, biotechnology, cardiovascular, cell therapy, dental, dermatology, diagnostics, drug delivery, endocrine, gastroenterology, gynecology, imaging, neurology, oncology, ophthalmology, orthopedics, pain management, patient monitoring, respiratory, spine, surgery, urology, vascular, and wound management.

More information on the EMT Database, along with the complete list of emerging medical technologies (728 and growing), can be found at www.emergingmedicaltechnologies.com .

A free trial to the database is available at http://lifescienceintelligence.com/free-trial.php .

Firms and companies that have invested in or partnered with companies in the EMT Database include: Accuitive Ventures, Advanced Technology Ventures, Aesculap, Affinity Capital Partners, Alta Partners, Baird Venture Partners, Battelle Ventures, Bay City Capital, Boston Scientific (BSX), Canaan Ventures, Conmed (CNMD), Covidien (COV), CR Bard (BCR), Delphi Ventures, Domain Associates, Edwards Lifesciences (EW), Essex Woodlands, Frazier Healthcare Ventures, Galen Partners, Heidelberg Innovation, JJDC, Johnson & Johnson (JNJ), JP Morgan, Medtronic (MDT), Microsoft (MSFT), Morgenthaler Ventures, MPM Capital, NASA, Onset Ventures, Oxford BioScience Partners, Path4 Ventures, Prism Venture Partners, Rivervest Venture Partners, Sanderling Ventures, Sapient Capital, Schroder Ventures, Sofinnova Ventures, Split Rock Partners, St. Jude (STJ), Stryker (SYK), SV Life Sciences, Sycamore Ventures, Trialthlon Medical Ventures, Versant Ventures, and Welch Allyn.

About Life Science Intelligence (LSI)
Life Science Intelligence (LSI) delivers high-quality market data and information to medical technology executives, entrepreneurs, and investors. LSI produces the EMT (Emerging Medical Technologies) Database, medtech market reports, and provides custom research services, including market assessments and physician surveys. In addition, LSI partners with top-tier information companies such as Health Research International (HRI) and Windhover/Medtech Insight to distribute their high-end information products. www.LSintelligence.com .

Contact:
Life Science Intelligence, Huntington Beach
Scott Pantel, 714 847 3540
scott@LSintelligence.com
www.lsintelligence.com